Virax Biolabs Files March 2025 6-K Report
Ticker: VRAX · Form: 6-K · Filed: Mar 5, 2025 · CIK: 1885827
| Field | Detail |
|---|---|
| Company | Virax Biolabs Group Ltd (VRAX) |
| Form Type | 6-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulatory-update, foreign-issuer
TL;DR
Virax Biolabs filed a 6-K on 3/5/25, standard foreign issuer update.
AI Summary
Virax Biolabs Group Ltd. filed a Form 6-K on March 5, 2025, to report information for the month of March 2025. The filing indicates the company is a foreign private issuer and files annual reports under Form 20-F. The principal executive offices are located in Lanarkshire, United Kingdom.
Why It Matters
This filing provides routine updates for investors and regulators regarding Virax Biolabs Group Ltd.'s status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that does not appear to contain significant new financial or operational information.
Key Players & Entities
- Virax Biolabs Group Ltd. (company) — Registrant
- March 5, 2025 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Form
- BioCity Glasgow (location) — Principal Executive Offices
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange on which its securities are traded.
When was this Form 6-K filed?
This Form 6-K was filed on March 5, 2025.
What is the company's name and principal executive office location?
The company's name is Virax Biolabs Group Limited, and its principal executive offices are located at BioCity Glasgow, Bo'Ness Road, Newhouse, Lanarkshire, ML1 5UH, United Kingdom.
Does Virax Biolabs Group Ltd. file annual reports under Form 20-F or 40-F?
Virax Biolabs Group Ltd. files annual reports under Form 20-F.
What is the SIC code for Virax Biolabs Group Ltd.?
The Standard Industrial Classification (SIC) code for Virax Biolabs Group Ltd. is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 5, 2025 regarding Virax Biolabs Group Ltd (VRAX).